GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neurotech International NTI.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.02

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Neurotech International — daily ASX:NTI

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Neurotech International on TradingView ↗
Market value
A$20.7m
Last close × shares
Volume
493.3k
Shares, 9 Nov 2026

About Neurotech International

Its shares trade on ASX under the ticker NTI.AX. It has been listed since 4 November 2016. In the fiscal year to 30 June 2025, it reported revenue of A$2.4m and a net loss of A$10.6m. At that date it held total assets of A$3.2m and shareholders' equity of A$3.0m.

Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm is focused on the development and commercialization of neurological solutions focused predominately on pediatric neurological disorders. The firm conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its NTI/Dolce cannabis strains. The company is also commercializing Mente, a home therapy to increase engagement and improve relaxation in autistic children with elevated delta-band brain activity. Its product, Mente Autism, assists with the management of children with autism spectrum disorder (ASD). Its development program NTI164 completed a Phase I/II clinical trial to treat patients with autism spectrum disorder (ASD). Mente Autism is a portable, electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to helo-relax the minds of children with ASD.

Figures and description from our data supplier, not checked against the company's own report.

More about Neurotech International →

Latest on Neurotech International

Our reporting

We have not reported on Neurotech International yet.

Next results

2 Mar 2027

Due on 2 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Neurotech International's ticker?

Neurotech International trades as NTI.AX on ASX, under ISIN AU000000NTI9.

What was Neurotech International's last closing price?

0.02 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Neurotech International next report results?

Results are expected on 2 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.